Pulse.

a daily field guide to health research that matters

◆ Console

‹ Wed · 1 Apr 2026
Underserved or high-risk populations

Stem cell transplantation and gene therapy for telomere biology disorders: Historical perspective, current approaches, and emerging strategies.

Gentler transplant approaches and emerging gene therapies offer patients with telomere disorders new hope for safer, longer-lasting remissions.

This review covers advances in treating telomere biology disorders, including improved reduced-intensity transplant regimens and emerging gene therapies for telomere elongation. Long-term post-transplant surveillance remains essential due to progressive organ dysfunction.

What the study was

Study design
Review
Population
Patients with telomere biology disorders
Category
Treatment Innovation
Maturity
Validated
Journal
Seminars in Hematology

Why it surfaced

Comprehensive review on rare telomere biology disorders with gene therapy discussion. High unmet need but review format limits score.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.